Segantii Capital Management LTD Avrobio, Inc. Transaction History

Segantii Capital Management LTD

  • $807 Million
  • Q1 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 13, 2020
SELL
$12.19 - $22.96 $1.28 Million - $2.41 Million
-105,000 Closed
0 $0
Q1 2020

May 08, 2020
BUY
$10.08 - $27.21 $1.06 Million - $2.86 Million
105,000 New
105,000 $1.63 Million

Others Institutions Holding AVRO

# of Institutions
1
Shares Held
559K
Call Options Held
0
Put Options Held
0
View Full List

About AVROBIO, Inc.

AVRO Quotes by TradingView
  • Ticker AVRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,773,900
  • Description
  • AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...
More about AVRO
Track This Portfolio

Track Segantii Capital Management LTD Portfolio

Follow Segantii Capital Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Segantii Capital Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Segantii Capital Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email